Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars

American Journal of Dermatopathology

Volumn 33, Issue 1, 2011, Pages 84-91

  Abdou, Asmaa Gaber ^a   Maraee, Alaa Hassan ^a   Al Bara, Ahmed Mohamed ^a   Diab, Wafaa Mohammed ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

hypertrophic scar; keloid; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENDOTHELIUM CELL; EPIDERMIS; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KELOID; KERATINOCYTE; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; SKIN BIOPSY; SKIN FIBROBLAST;

ADOLESCENT; ADULT; CHILD; CICATRIX, HYPERTROPHIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KELOID; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING; YOUNG ADULT;

EID: 78951495456     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181d0c3ad     Document Type: Article

References (24)

1. Al-Attar A, Mess S, Thomassen JM, et al. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117:286-300.
2. Ehrlich HP, Desmoulière A, Diegelmann RF, et al. Morphological and immunological differences between keloid &hypertrophic scar. Am J Pathol. 1994;145:105-113.
3. Yu H, Bock O, Bayat A, et al. Decreased expression of inhibitory SMAD 6 and SMAD 7 in keloid scarring. J Plast Reconstr Aesthet Surg. 2006;59: 221-229.
4. Border WA, Noble NA. Transforming growth factor b in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
5. Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor β(1). Am J Respir Cell Mol Biol. 1999;21:658-665.
6. Pandit A, Ashar R, Feldman D. The effect of TGF-beta delivered through a collagen scaffold on wound healing. J Invest Surg. 1999;12:89-100.
7. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol. 2002;161:895-907.
8. Bock O, Yu H, Zitron S, et al. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Dermatol Venereol. 2005;85:216-220.
9. Lee TY, Chin GS, Kim WJ, et al. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg. 1999;43:179-184.
10. Frank S, Madlener M, Werner S. Transforming growth factor- b1, 2 and 3 and their receptors are differentially regulated in normal and impaired wound healing. J Biol Chem. 1996;271:10188-10193.
11. Hakvoort TE, Altun V, van Zuijlen PPM, et al. Transforming growth factor- b1, 2 and 3, basic fibroblast growth factor and vascular endothelial expression in keratinocytes of burn scars. Eur Cytokine Netw. 2000;11: 233-239.
12. Kuwano K, Hagimoto N, Nakanishi Y. The role of apoptosis in pulmonary fibrosis. Histol Histopathol. 2004;19:867-881.
13. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;15:3964-3972.
14. Suematsu M, Suzuki H, Delano FA, et al. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation. 2002;9:259-276.
15. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218.
16. Strieter RM, Gomperts BN, Keane MP. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest. 2007;117:549-556.
17. Schmid P, Cox D, Bilbe G, et al. TGF-beta s and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol. 1993;171:191-197.
18. Tuli SS, Liu R, Chen C, et al. Immunological localization of EGF, TGFalpha, TGF-beta and their receptors in rat corneas during healing of excimer laser ablation. Curr Eye Res. 2006;31:709-719.
19. Maas-Szabowski N, Fusenig NE. Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol. 1996; 107:849-855.
20. Martin P. Wound healing aiming for a perfect skin regeneration. Science. 1997;276:75-81.
21. Pastar I, Stojadinovic O. Tormic-canic M.Stojadinovic O. Tormic-canic M. Role of keratinocytes in healing of chronic wound. Surg Techno Int. 2008;17:105-112.
22. Tandara AA, Mustoe TA. The role of the epidermis in the control of scarring: evidence for mechanism of action for silicone gel. J Plast Reconstr Aesthet Surg. 2008;61:1219-1225.
23. Buss A, Pech K, Kakulas BA, et al. TGF-beta1 and beta 2 expression after traumatic human spinal cord injury. Spinal Cord. 2008;46:364-371.
24. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-b1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994;93:11721-11778.